Cellectis (CLLS) Current Assets (2013 - 2026)
Cellectis (CLLS) reported Current Assets of $184.42 million for Q2 2026, down 20.0% from $230.64 million a year earlier and down 9.8% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Cellectis posted Current Assets of $236.24 million, down 17.7% from FY2024.
- Current Assets has a five-year compound annual growth rate of -5.6% (FY2020 to FY2025).
- By year, Current Assets came in at $287.07 million in FY2024 (+23.2%), $233.01 million in FY2023 (+90.9%), $122.04 million in FY2022 (-45.9%) and $225.43 million in FY2021 (-28.5%).
- The Q2 2026 figure ranks as the lowest quarterly Current Assets since Q3 2023.
- Year over year, Current Assets has now declined in each of the last five quarters, with growth averaging 15.2% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q3 2024 (growth of 205.1%); the low point was Q4 2022 (a decline of 45.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $204.55 million (Q1 2026), $236.24 million (Q4 2025) and $221.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Cellectis | 148.50 Mn | -604.89 Mn | - | 184.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 184.42 Mn |
| Mar 31, 2026 | 204.55 Mn |
| Dec 31, 2025 | 236.24 Mn |
| Sep 30, 2025 | 221.19 Mn |
| Jun 30, 2025 | 230.64 Mn |
| Mar 31, 2025 | 271.83 Mn |
| Dec 31, 2024 | 287.07 Mn |
| Sep 30, 2024 | 294.43 Mn |
| Jun 30, 2024 | 305.80 Mn |
| Mar 31, 2024 | 258.07 Mn |
| Dec 31, 2023 | 233.01 Mn |
| Sep 30, 2023 | 96.49 Mn |
| Jun 30, 2023 | 113.29 Mn |
| Mar 31, 2023 | 117.23 Mn |
| Dec 31, 2022 | 122.04 Mn |
| Sep 30, 2022 | 140.27 Mn |
| Jun 30, 2022 | 175.17 Mn |
| Mar 31, 2022 | 195.18 Mn |
| Dec 31, 2021 | 225.43 Mn |
| Sep 30, 2021 | 235.85 Mn |
API Access
Cellectis Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();